Mycenax Biotech Inc Sustainability Reports

Mycenax Biotech Inc. is a contract development and manufacturing organization (CDMO) specializing in biologics. The company provides end-to-end services from cell line development and process engineering to clinical and commercial good manufacturing practice (GMP) production.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG001T3S552

13 reports from 2022 to 2025

• Mycenax Biotech Inc 2025 Sustainability Report
• Mycenax Biotech Inc 2025 Greenhouse Gas Reduction Management Policy
• Mycenax Biotech Inc 2025 Measures for Protecting Work Environment and Employee Personal Safety and the Implementation Status
• Mycenax Biotech Inc 2025 Individual Financial Report and Independent Auditor's Report
• Mycenax Biotech Inc 2025 Annual Report